WeChat Share

COMMITTEES

<span style="font-family: arial,helvetica,sans-serif;;">Untitled Document</span>


Steering Committee

Jingsong WANG, MD

Adviser, Atlas Venture

Xiaoxiang CHEN, MD

Vice President, Medicine Development, Greater China, Boehringer Ingelheim

Janet LV

Head of Regulatory, Asia Pacific, Roche (China) Ltd.

Ling SU, PhD

Strategic Advisor, Life Sciences, Sidley Austin LLP

Ning XU, MD, MBA

Executive Vice President, Head of Clinical Development and Regulatory Affairs, Zai Lab

Carol ZHU, MBA

Senior Vice President and Managing Director, DIA Greater China

Program Committee

Haifeng CAO

Head of Regulatory Affairs, GSK

Lili CAO

Director, Division of External Cooperation, CCFDIE, CFDA

Xiaochun CAO, MPS

Executive Vice President & Board Secretary, Tigermed Consulting Ltd.

George CHEN, MD, MBA

Vice President and Head of Global Medicine Development China, AstraZeneca (China)

Paul DAI, MD

Senior Director, Regional Head of ICRO, AMAC/Greater China Region (Asia Pacific, Middle East and African Countries/Greater China Region), Beijing Novartis Pharma Co., Ltd.

Yazhong DENG, MBA

Head of Clinical Data Analysis and Reporting Organization (CDARO), Covance

Frank FAN, MD, MBA

Senior Medical Director, Head of Medical & Scientific Services, Greater China, Quintiles

Tony GUO

Director, Biostatistics, MSD R&D (China) Co, Ltd.

Min IRWIN, MD, PhD

Vice President, Medicines Development, GlaxoSmithKline

Amy JIANG

Quality Operations, China/AP R&D, Sanofi

Helen LI, MD, MBA

Director, Emerging Market QA, Asia Lead, Pfizer Medical - Quality Assurance, Pfizer (China) Research and Development Co., Ltd.

Joy LI, MD, PhD, MBA

Director, Pharmacovigilance and Medical Information, BMS China R&D

Shuting LI, MD

Director, GCP Center, the Cancer Hospital of Chinese Academy of Medical Sciences

Vera  LIANG, MD

Global Safety Risk Lead and Director, Safety Surveillance and Risk Management, Pfizer China R&D Center, Pfizer (China) Research and Development Co., Ltd.

Jane LIN, MD

Vice President, Strategic Medical Affairs, Johnson & Johnson Medical (China) Ltd.

Melly LIN

Senior Regulatory Manager, CMC Policy, Roche (China) Holding Ltd.

Jessica LIU, MD

VP Clinical Development, General Medicine BU, Asia-Pacific Region, INC Research

Roger QU, PhD

Head of Clinical Statistics, Pfizer R&D Center

Hualong SUN, MD, PhD

General Manager, Meta Clinical Technology

Xiaoling WANG

Head of Clinical Documentation, Clinical Science Operation, Sanofi R&D

Xiuqin WANG, PhD

Deputy Director, Department of Science and Technology, Jiangsu Province Hospital, First Affiliated Hospital with Nanjing Medical University

Jielai XIA

Professor, Department of Medical Statistics, 4th Military Medical University

Jack XU, MD

Senior Vice President, Shanghai Clinical Research Center

Charles YAN, PhD

Senior Director, Data Management and Biometrics, Shanghai Hengrui Medicine Co, Ltd.

James YAN, MD, PhD, DABT

Executive Vice President, Head of Early Development and Drug Safety, Zai Lab

Wendy YAN, MD, MBA

Senior Vice President, Head of Regulatory/Affairs, BeiGene (Beijing) Co., Ltd.

Joe ZHANG, MD, PhD

Executive Deputy, Head of Center of Medical and Translational Sciences;
Founder and Member, R&D Committee, Group Leader, R&D Working Group, Shanghai CP GuoJian Pharmaceutical Co. Ltd.

Mingping ZHANG

Principal Consultant, PAREXEL Consulting

Ling ZHEN, JD, MBA

Vice President, Greater China, Quintiles